2021 Year-End Review / 2021年総括
2021年の良かった点：
RBM20変異により起こる心筋症に関する論文発表
ウィルソン病原因のATP7B変異に関する論文を、理研の林先生と共同でbioRxivに発表、論文査読中
齋藤さんが優秀学生賞を受賞
近藤さんが現実世界の学会でポスター発表（卒業までに経験できてよかった）
企業との共同研究が進んだ
多くの鍵となる実験結果を得た
2022年に改善が必要な点：
論文発表（毎年）
研究費獲得（人が雇える規模が理想）
適材適所の人と研究テーマの布陣形成
2021年も感染症の脅威から抜け出すことはできず、多くの制限が残された中での研究活動となりましたが、2020年よりも若干やれることが増えた気がします。卒業までに一度は発表をしてもらいたいので、近藤さんがポスター発表できてよかったです。2020年に減らしすぎたマウスの数も回復して、前々から計画していた実験をやっと進めることもできました。いくつか、とてもおもしろい結果も得られたので、今後につなげていきたいです。そのためにベストの布陣を考えます。
ずっと続けてきた、RBM20に関する論文を発表できたことには、本当に安心しましたが、2022年も引き続いて論文が発表できるよう、努力するしかないです。その成果を研究費、特に人を雇えるくらいの規模のもの、の獲得につなげていきたいと思います。人を雇えることの偉大さを、PIになって実感しております。
ひとまずは、みなさんが心身ともに健康であったことはよかったです。2022年には研究室の人が入れ替わりますが、引き続き楽しんで研究ができる環境を作れるようにしたいと思います。そろそろ学会とか出張とか、行きたいです…
Good things in 2021
Paper on cardiomyopathy caused by RBM20 mutations published. Paper on ATP7B mutations that cause Wilson's disease published at bioRxiv and under review in collaboration with Dr. Hayashi's lab at RIKEN.
Anri Saitoh won the best student award. Daiki Kondo presented his poster in a real in-person meeting (good that he did this before his graduation).
Great progress in some collaborative projects with companies.
Several key results in lab projects.
Things that need improvements in 2022:
Paper (as always)
Grants (ideally big enough to hire a postdoc)
Find the best arrangements of lab projects and people to move forward as a lab
The year 2021 was still significantly affected by the pandemic. Our research activities still had a lot of restrictions, but I felt things were slightly better than in 2020. I always hope that students can present their work at academic meetings at least once before graduation, so I was glad to see that Daiki Kondo was able to attend a real meeting this year. We had reduced the number of mice too much last year, but it recovered this year, so that we were finally able to conduct some animal experiments that we had designed long before. Besides, we also got some very interesting results. I hope these will lead to new projects. For that purpose, I will find the best organization of projects and people in the lab.
Our paper on RBM20 was finally out this year. I am so glad. I will keep trying my best to publish more in 2022 too. Hopefully that will lead to grants, especially a bigger one to hire a postdoc. As a PI, now I really appreciate how important and difficult to hire people.
Overall, we were healthy throughout the year, which is nice. We will have some personnel turnovers in 2022, but I will try to keep the healthy lab environments to enjoy lab life. Now I miss conferences and traveling though...
